Literature DB >> 11891190

Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

Andrew D Cook1, Emma L Braine, Ian K Campbell, John A Hamilton.   

Abstract

The plasminogen activators, urokinase PA (u-PA) and tissue-type PA (t-PA), are believed to play important roles in inflammatory cell infiltration, fibrin deposition, and joint destruction associated with rheumatoid arthritis; however, their precise roles in such processes, particularly u-PA, have yet to be defined. Using gene-deficient mice we examined the relative contribution of the PAs to the chronic systemic collagen-induced arthritis model. Based on clinical and histological assessments, u-PA-/- mice developed significantly milder disease and t-PA-/- mice more severe disease compared with the relevant wild-type mice. Fibrin deposition within joints paralleled disease severity and was particularly pronounced in t-PA-/- mice. Likewise, cytokine levels in the synovium reflected the severity of disease, with interleukin-1beta levels in particular being lower in u-PA-/- mice and increased in t-PA-/- mice. The antibody response to type II collagen was normal in both knockouts; however, T cells from u-PA-/- mice had a reduced proliferative response and produced less interferon-gamma on antigen stimulation in vitro. These results indicate that the major effect of u-PA in the collagen-induced arthritis model is deleterious, whereas that of t-PA is protective. Our data highlight the complexities of PA function, and suggest that approaches either to target u-PA or to enhance local t-PA activity in joints may be of therapeutic benefit in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891190      PMCID: PMC1867189          DOI: 10.1016/S0002-9440(10)64914-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin.

Authors:  K Matsushima; M Taguchi; E J Kovacs; H A Young; J J Oppenheim
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

Review 2.  Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.

Authors:  D Moscatelli; D B Rifkin
Journal:  Biochim Biophys Acta       Date:  1988-08-03

3.  Immunocytology in arthritic joints.

Authors:  M I Barnhart; J M Riddle; G B Bluhm
Journal:  Ann Rheum Dis       Date:  1967-07       Impact factor: 19.103

Review 4.  Cell-associated plasminogen activation: regulation and physiological functions.

Authors:  O Saksela; D B Rifkin
Journal:  Annu Rev Cell Biol       Date:  1988

5.  Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.

Authors:  J B Weinberg; A M Pippen; C S Greenberg
Journal:  Arthritis Rheum       Date:  1991-08

6.  IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

Authors:  L A Joosten; M M Helsen; T Saxne; F A van De Loo; D Heinegard; W B van Den Berg
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

7.  Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells.

Authors:  T Leizer; B J Clarris; P E Ash; J van Damme; J Saklatvala; J A Hamilton
Journal:  Arthritis Rheum       Date:  1987-05

8.  Recombinant human interleukin-1 inhibits plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes.

Authors:  I K Campbell; K Last; U Novak; L R Lund; J A Hamilton
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

9.  Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator.

Authors:  I K Campbell; D S Piccoli; D M Butler; D K Singleton; J A Hamilton
Journal:  Biochim Biophys Acta       Date:  1988-11-17

10.  Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.

Authors:  N Seki; Y Sudo; T Yoshioka; S Sugihara; T Fujitsu; S Sakuma; T Ogawa; T Hamaoka; H Senoh; H Fujiwara
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

View more
  18 in total

1.  Porphyromonas gingivalis-derived RgpA-Kgp Complex Activates the Macrophage Urokinase Plasminogen Activator System: IMPLICATIONS FOR PERIODONTITIS.

Authors:  Andrew J Fleetwood; Neil M O'Brien-Simpson; Paul D Veith; Roselind S Lam; Adrian Achuthan; Andrew D Cook; William Singleton; Ida K Lund; Eric C Reynolds; John A Hamilton
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

2.  GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model.

Authors:  Roselind S Lam; Neil M O'Brien-Simpson; John A Hamilton; Jason C Lenzo; James A Holden; Gail C Brammar; Rebecca K Orth; Yan Tan; Katrina A Walsh; Andrew J Fleetwood; Eric C Reynolds
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

Review 3.  The multifaceted role of fibrinogen in tissue injury and inflammation.

Authors:  James P Luyendyk; Jonathan G Schoenecker; Matthew J Flick
Journal:  Blood       Date:  2018-12-06       Impact factor: 22.113

4.  Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.

Authors:  Jakub Kwieciński; Elisabet Josefsson; Tao Jin
Journal:  Inflamm Res       Date:  2011-07-24       Impact factor: 4.575

5.  Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.

Authors:  Martin O Judex; Barbara M Mueller
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.

Authors:  Jinan Li; Annelii Ny; Göran Leonardsson; Kutty Selva Nandakumar; Rikard Holmdahl; Tor Ny
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.

Authors:  Rikke Stagaard; Carsten Dan Ley; Kasper Almholt; Lisbeth Høier Olsen; Tom Knudsen; Matthew J Flick
Journal:  Blood Adv       Date:  2018-11-27

8.  Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Authors:  Andrew D Cook; Christine M De Nardo; Emma L Braine; Amanda L Turner; Ross Vlahos; Kerrie J Way; S Kaye Beckman; Jason C Lenzo; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

9.  Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice.

Authors:  Harini Raghu; Alice Jone; Carolina Cruz; Cheryl L Rewerts; Malinda D Frederick; Sherry Thornton; Jay L Degen; Matthew J Flick
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

10.  Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage.

Authors:  D D Chan; W F Xiao; J Li; C A de la Motte; J D Sandy; A Plaas
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.